Kim, D. Y., Kim, J. H., Tak, W. Y., Yeon, J. E., Lee, J. H., Yoon, J. H., . . . Lee, H. C. (2017). Baracle(®) vs Baraclude(®) for 48 weeks in patients with treatment-naïve chronic hepatitis B: A comparison of efficacy and safety. Drug Des Devel Ther.
Citación estilo ChicagoKim, Do Young, et al. "Baracle(®) Vs Baraclude(®) for 48 Weeks in Patients With Treatment-naïve Chronic Hepatitis B: A Comparison of Efficacy and Safety." Drug Des Devel Ther 2017.
Cita MLAKim, Do Young, et al. "Baracle(®) Vs Baraclude(®) for 48 Weeks in Patients With Treatment-naïve Chronic Hepatitis B: A Comparison of Efficacy and Safety." Drug Des Devel Ther 2017.
Precaución: Estas citas no son 100% exactas.